Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
27/09/2022 17:01
Sept 27 (Reuters) - AcuCort AB ACUC.TE :
* ACUCORT RECEIVES MARKETING AUTHORIZATION FOR DRUG ZEQMELIT
BY
NORWEGIAN MEDICINES AGENCY
Source text for Eikon: ID:nWkr192Bw5
Further company coverage: ACUC.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA